FTC sues main pharmacy benefit managers around insulin price ranges The company introduced action against Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the record cost of life-preserving insulin medications. Elevance lowers direction on ‘unprecedented’ Medicaid problems Executives said the improved exp... https://aya-healthcare-address51840.bloggactivo.com/30108053/the-ultimate-guide-to-healthcare-news